The mechanism of influenza virus (INFV)-induced immunosuppression and the mode of inosiplex action against INFV infection were studied. INFV suppressed both anti-lipopolysaccharide and anti-sheep erythrocyte antibody production in mice. INFV infection caused viral mRNA synthesis and increased total RNA synthesis in lymphocytes, but total mRNA synthesis was decreased. The translational ability of INFV-infected lymphocytes was also suppressed. Thus, INFV seemed to cause suppression of both mRNA synthesis and the translational ability of lymphocytes, resulting in suppression of lymphocyte functions. Inosiplex potentiated antibody production against sheep erythrocytes but not against lipopolysaccharide in normal and INFV-infected mice. Adamantanamine did not produce such a potentiating effect. The lymphocytes obtained from INFVimmunized and inosiplex-treated mice conferred resistance against INFV infection. This resistance was partially inhibited by anti-Thy 1.2 antibody treatment of the lymphocytes. In an adoptive cell transfer system, inosiplex treatment of T-cell donors potentiated antibody production when a non-immunosuppressive carrier (human serum albumin) was used. When an immunosuppressive carrier (INFV) was used, inosiplex treatment of either B-cell donors or T-cell donors increased antibody production. Direct introduction of inosiplex into lymphocytes by a cell fusion technique stimulated anti-sheep erythrocyte antibody production more effectively than the addition of inosiplex to cultures. Inosiplex increased total RNA and total mRNA syntheses in phytohemagglutinin-treated lymphocytes. In INFV-infected lymphocytes, inosiplex decreased syntheses of total RNA, total mRNA, and viral mRNA and restored translational ability. From these results, we concluded that inosiplex penetrates into lymphocytes and suppresses viral RNA synthesis and that it supports lymphocyte functions by promoting RNA synthesis and translational ability, both of which are necessary for hosts.
Inosiplex, which is a complex of inosine and N,N-dimethylamino -2 -propanol -p -acetamidobenzoate (DIP-PACBA) at a molar ratio of 1:3 (20; P. Gordon, U.S. patent 3, 646, 007, 1972) , inhibits viral growth (6, 7, 17) and also enhances immune responses, such as promotion of mitogen-stimulated T-lymphocyte proliferation and augmentation of antibody production and delayed-type hypersensitivity (8, 19) .
Immune responses are suppressed by viral infections (16) , and immunosuppression has to contribute to the progression of viral diseases. Therefore, if a compound both possessed the potency to restore the immune response in a virally infected host and could inhibit viral growth, it would be useful in the therapy of viral infections. We have reported previously that virus-induced immunosuppression is restored by inosiplex but not by immunopotentiators, such as levamisole, PS-K, and OK-432 (18) . This finding clearly indicates that virus-induced immunosuppression is not the same as cyclophosphamide-or hydrocortisone-induced immunosuppression, which is restored by levamisole, PS-K, or OK-432, and that a compound which restores virus-induced immunosuppression could be developed as an antiviral agent.
In the present study, we investigated the mechanism of virus-induced immunosuppression, the effect of inosiplex on the immune response of infected mice, and the mode of action of inosiplex as an antiviral agent. made with [8-14C] inosine (59 mCi/mmol; Amersham Corp.) and DIP-PACBA, and 3H-labeled DIP-PACBA was prepared with p-acetamido- [3,5-3H] (22) , or SRBC in Eagle minimal essential medium (Flow). After 40 min of incubation, both the number of hemolytic PFC (direct PFC) and the number of hemolytic PFC after the addition of rabbit antimouse immunoglobulin G antibody (indirect PFC) were counted (3, 19) .
Antibody production in vivo. Groups of six male ddY mice were given either 100 ,ug of LPS or 101 SRBC intravenously. After 1 h, inosiplex (10, 30, or 100 mg/ kg) was given orally. After 4 days, the spleen cells were obtained, and direct anti-LPS and anti-SRBC PFC were measured.
Other groups of mice were inoculated with 10'-50% tissue culture infective doses (TCID50) of INFV i.p. At 1 h after inoculation, either LPS or SRBC were injected, and after another 1 h either inosiplex or adamantanamine (100 mg/kg) was administered to the animals. Direct anti-LPC PFC (29) and direct anti-SRBC PFC (3) were measured 4 days after viral inoculation.
Antibody production in vitro. A total of 6 x 106 lymphocytes obtained from female DBA/2 mice were cultured with 1.2 x 107 SRBC and inosiplex (1, 10, or 100 ,Lg/ml) in 2 ml of medium for 6 days, and direct anti-SRBC PFC were then measured. A total of 6 x 106 lymphocytes which were precultured with 105 2 TCID50 of INFV for 1 h were also cultured with SRBC and inosiplex for 6 days for the measurement of direct anti-SRBC PFC.
Host defense induced by transfer of lymphocytes. Ten female ICR mice were used per group. (9) .
At 1 h after the cell transfer, each recipient mouse was challenged i.p. with DNP-HSA (100 ,ug). At 7 days after the cell transfer, spleen cells were obtained to measure direct and indirect anti-DNP PFC (22) .
Lymphocytes were obtained from a DNP-KLHimmunized mouse and from an HSA-immunized, inosiplex-treated mouse, and these cells were transferred to X-irradiated mice. The recipient mice were challenged with DNP-HSA, and direct and indirect anti-DNP PFC were measured.
( Separately, lymphocytes from a DNP-KLH-immunized mouse were mixed with lymphocytes from an INFV-immunized, inosiplex-treated mouse and transferred to recipient mice. The recipient mice were challenged with DNP-INFV, and direct and indirect anti-DNP PFC were measured.
Effect of intracellular inosiplex on antibody production. Guinea pig erythrocyte ghosts, which were introduced with inosiplex or its constituents, were prepared by the method of Yamaizumi et al. (28) . UV-inactivated HVJ virus (103 hemagglutination units) was added to 2 ml of a balanced salt solution containing 6 x 108 ghosts and 6 x 106 lymphocytes from female DBA/2 mice. The ghost-fused lymphocytes obtained were cultured in 2 ml of medium with 1.2 x 107 SRBC for 6 days, and direct anti-SRBC PFC were then measured.
"C-labeled inosiplex, "C-labeled inosine, and 3H-labeled DIP-PACBA were introduced into lymphocytes in place of inosiplex, inosine, and DIP-PACBA, respectively. The radioactivities of these lymphocytes were measured with a liquid scintillation counter (type LSC-65A; Aloka), and the amounts of intracellularly introduced compounds were calculated.
Direct anti-SRBC PFC of the lymphocytes which were fused with drug-free ghosts were measured after incubating the cells with inosiplex (10, 100, or 1,000 ,ug/6 x 106 lymphocytes) and SRBC for 6 days.
RNA synthesis in lymphocytes. A total of 108 lymphocytes from female DBA/2 mice were precultured with These lymphocytes were cultured with inosiplex (10 p.g/ml) for 3 h. Then the cells were cultured with [5- 3H]uridine (30 Ci/mmol; Amersham) at a final concentration of 10 ,uCi/ml for 1 h (25) and homogenized. The phenol-chloroform extract of the resulting homogenate was prepared as the total RNA fraction (26) . This fraction was separated with polyuridylic acid-Sepharose (Pharmacia), and the total mRNA fraction was obtained as the eluent (14) . In addition, the viral mRNA fraction was obtained by annealing the total mRNA fraction with viral RNA (22) , followed by treatment with RNase A and RNase T, (12) . The radioactivity of each fraction was counted as an indication of RNA synthesis. The effects of inosiplex on RNA and mRNA syntheses in uninfected cells were also measured.
Translational ability of a cell-free extract from lym- RESULTS Antibody production. INFV infection decreased direct anti-SRBC PFC and direct anti-LPS PFC. Inosiplex treatment increased direct anti-SRBC PFC in both normal and INFV-infected mice. However, inosiplex had no influence on direct anti-LPS PFC in either normal or infected mice. Adamantanamine had no effect on direct anti-SRBC and anti-LPS PFC in infected mice (Table 1 ).
In the in vitro system, INFV infection decreased direct anti-SRBC PFC, and inosiplex treatment significantly reversed the decrease in PFC (Fig. 1) .
Host defense induced by transfer of lymphocytes. All mice infected with INFV died within 14 days. When mice were inoculated with lymphocytes from INFV-immunized mice, 50% of the animals survived after challenge with INFV. The same survival rate was observed when the lymphocytes were treated with anti-Thy 1.2 antibody and guinea pig complement before the cells were transferred.
In contrast, when the recipient mice received lymphocytes from INFV-immunized, inosiplextreated mice, no death was observed in the mice after viral challenge. This protective effect of inosiplex was weakened when the transferred lymphocytes were treated with anti-Thy 1.2 antibody and guinea pig complement (Fig. 2a and b) .
Antibody production examined by adoptive cell transfer. Direct and indirect anti-DNP PFC were increased significantly when mice were inoculat- ed with lymphocytes from an HSA-immunized, inosiplex-treated mouse and from a DNP-KLHimmunized mouse and then challenged with DNP-HSA. However, no effect was observed when inosiplex was given to the DNP-KLHimmunized donors (Table 2) .
Similarly, direct and indirect anti-DNP PFC were increased when inosiplex was given to INFV-immunized mice and not to DNP-KLHimmunized mice. When the drug was given to the DNP-KLH-immunized mice, indirect anti-
DNP PFC were increased, and direct anti-DNP PFC were not increased ( Table 2) .
Effect of intracellular inosiplex on antibody production. The relationship between the amount of intracellularly introduced drug, which was measured by using radiolabeled compounds, and direct anti-SRBC PFC showed that intracellularly introduced inosiplex significantly increased direct anti-SRBC PFC at a dose of 0.1 ,ug/6 x 106 lymphocytes, but intracellularly introduced inosine or DIP-PACBA did not show any effect (Fig. 3a) .
Extracellular inosiplex that was added to medium containing lymphocytes which had been fused with drug-free ghosts also increased the direct anti-SRBC PFC of the fused cells at a concentration of 100 ,ug/6 x 106 lymphocytes (1,000 times the effective concentration of intracellularly introduced inosiplex) (Fig. 3b) .
RNA synthesis in lymphocytes. Inosiplex did not affect total RNA and total mRNA syntheses in normal lymphocytes. PHA increased total RNA and total mRNA syntheses by 98 and 66%, respectively, both of which were further augmented by inosiplex.
INFV infection increased total RNA synthesis by 18%, decreased total mRNA synthesis by 28%, and caused viral mRNA synthesis in lymphocytes. Inosiplex reduced total RNA and total mRNA syntheses in INFV-infected lymphocytes. Viral mRNA synthesis was reduced significantly by inosiplex (Table 3) .
Translational ability of a cell-free extract from lymphocytes. Inosiplex increased the translational ability of a cell-free extract from normal lymphocytes. PHA alone also increased the translational ability by 15%, and inosiplex augmented the PHA-induced increase.
INFV infection reduced the translational ability of the cell-free extract from INFV-infected lymphocytes by 77%. Treatment of the INFVinfected lymphocytes with inosiplex attenuated the decrease in the translational ability to 69% (Table 4) .
DISCUSSION
It has been reported previously that inosiplex inhibits viral growth (6, 7, 17) and potentiates immune responses (8, 19, 23 In the present study, the mechanism of infection-induced immunosuppression and the mode of immunopotentiation of inosiplex in infected animals were studied. We also studied the inhibitory effects of the potentiation of T-cell function on experimental viral infections. Recipient mice which were inoculated with lymphocytes from INFV-immunized mice acquired resistance to INFV challenge, and this resistance was not weakened by treating the lymphocytes with anti-Thy 1.2 antibody and complement. These findings suggest that resistance was mediated by anti-Thy 1.2 antibody-insensitive cells. This resistance was enhanced by treating the INFV-immunized mice with inosiplex. As this enhancement by inosiplex was partially inhibited by treating the lymphocytes with anti-Thy 1.2 antibody and complement, it was mediated both by anti-Thy 1. Therefore, the anti-Thy 1.2 antibody-insensitive lymphocytes, which mediated host defense, seemed to be non-T cells which were derived by inosiplex-induced potentiation of the T-cell function, and the host defense potentiation by inosiplex seemed to be T cell mediated.
In addition, the interaction between inosiplex and lymphocytes was studied. Inosiplex was introduced into lymphocytes by the ghost fusion method. Intracellularly introduced inosiplex increased PFC as well as extracellularly added inosiplex did. The optimal concentration of intracellularly introduced inosiplex was about 1,000 times lower than the optimal concentration of extracellularly added inosiplex. Each constituent of inosiplex (inosine or DIP-PACBA) did not affect the PFC in the lymphocytes when it was introduced into cells. These findings suggested that inosiplex penetrated the cells as a complex and modulated the lymphocyte functions.
Nucleic acid synthesis and translational ability in infected lymphocytes were investigated as an indication of lymphocyte function. Inosiplex did not influence total RNA and mRNA syntheses in normal lymphocytes. In PHA-treated lymphocytes, total RNA and mRNA syntheses were significantly increased compared with syntheses in normal cells. Inosiplex caused further increases in total RNA and mRNA syntheses in PHA-treated lymphocytes. These results are in good agreement with the finding that inosiplex did not show mitogenic action by itself but promoted proliferation of lymphocytes which were already "triggered" by T-cell mitogens, such as PHA and concanavalin A (8, 19) .
In INFV-infected lymphocytes, total RNA synthesis was increased. This is in good agreement with the finding that RNA synthesis by host cells is necessary for INFV growth (2, 5, 27) . Accordingly, an increase in mRNA synthesis after INFV infection was expected, but total mRNA synthesis actually decreased. This decrease could have been the result of the fact that the increase in mRNA synthesis necessary for INFV growth was smaller than the decrease in mRNA synthesis necessary for the host (13) because viral infection suppresses protein synthesis by the host (15) .
Inosiplex reduced total RNA and mRNA syn-
